a dose- and time-response study using different doses of an inhaled derivative of atropine , ( 8r ) -3alpha-hydroxy-8-isopropyl-1 ah , 5ah-tropaniumbromide- ( +/- ) -tropate ( sch 1000 , ipratropium bromide , atrovent ) was performed in 12 patients with reversible chronic obstructuve airways disease .
C0700580
ipratropium bromide
C0591130
atrovent